Table 1.
Reagent | Description | Source or reference |
---|---|---|
E. coli | ||
DH5α | Φ80 dLacZΔM15 recA1 endA1 gyrA96 thi-1 hsdR17(rk- mk+) supE44 relA1 deoRΔ(lacZYA-argF)U169 | Promega |
S. aureus | ||
RN4220 | rk- mk+; accepts foreign DNA | [20] |
RN6390 | Prophage-cured wild-type strain | [21] |
Newman | Wild-type clinical isolate | [22] |
H803 | Newman sirA::Km; KmR | [30] |
H1665 | Newman Δsfa::Km; KmR | [9] |
H1666 | Newman Δsbn::Tet Δsfa::Km; TetR KmR | [9] |
H1262 | Newman Δhts::Tet; TetR | [9] |
H1497 | Newman sirA::Km Δhts::Tet; TetR KmR | [9] |
H2131 | Newman sbnA::Tc ΔsfaABCsfaD::Km | This study |
H1718 | Newman sbnB::Tc ΔsfaABCsfaD::Km | This study |
Plasmids | ||
pACYC184 | E. coli cloning vector; CmR | ATCC |
pALC2073 | E. coli/S. aureus shuttle vector; ApR CmR | [26] |
pAUL-A | Temperature-sensitive S. aureus suicide vector; EmR LcR | [25] |
pDG1514 | pMTL23 derivative carrying tetracycline resistance cassette; ApR | [24] |
pFB5 | pALC2073 derivative carrying sbnA; CmR | This study |
pSED52 | pALC2073 derivative carrying sbnB; CmR | This study |
Oligonucleotides* | ||
Cloning of sbnA into pBC SK+ | ||
sbnA5'-SacI | 5' TGAGCTCGATTCTGTAGGGCAAACACC 3' | |
sbnA3'-KpnI | 5' TTGGTACCTCTAAGTAACGATCGCCTCG 3' | |
Amplification/cloning of a tetracycline resistance cassette from pDG1513 | ||
Tet5'-NsiI | 5' TTGTATATGCATACGGATTTTATGACCGATGA 3' | |
Tet3' | 5' TGTGTGGAATTGTGAGCGGATAAC 3' | |
Cloning of sbnA into pALC2073 | ||
sbnA5'-XhoI | 5' TTTCTCGAGATTTTAAATTTGAGGAGGAA 3' | |
sbnA3'-EcoRI | 5' TTTGAATTCCCACATAAACTTGTGAATGATT 3' | |
Cloning of sbnB into pACYC184 | ||
sbnB5'-BamHI | 5' TTGGATCCTAGTTTATTCAGATACATGG 3' | |
sbnB3'-BamHI | 5' TTGGATCCTGTCCCAATATTTTGTTGTT 3' | |
Cloning of sbnB into pALC2073 | ||
sbnB5'-EcoRI | 5' TTGAATTCTCAAGTGATCCATGTAGATG 3' | |
sbnB3'-EcoRI | 5' TTGAATTCCAATTCCGGCTATATCTTCA 3' |
* underlined sequences in oligonucleotides denote restriction sites